The week before Christmas brought the biggest post-grant review (PGR) bulk filing to date, with 10 matters all stemming from a pharmaceutical dispute between Allergan and BTL Medical Technologies (and one other, unrelated). That’s a steady average of 30 inter partes reviews (IPRs) propped up by th Read More>>
Categories Courts, District Courts, Guest Contributors, IP News, IPWatchdog Articles, Litigation, Patents, USPTO, Guest Contributor, intellectual property, inter partes review, IPR, patent, patent infringement, Patent Litigation, patent office, Patent Trial and Appeal Board, patents, post grant procedures, PTAB
